- CRISPR interference reagents
- CRISPRi synthetic sgRNA positive controls
CRISPRmod CRISPRi synthetic sgRNA positive controls
Validated CRISPRi synthetic pools or individual sgRNA for optimization of transcriptional repression experiments

CRISPRi synthetic sgRNA positive controls will selectively repress a well characterized human gene (either PPIB1 or SEL1L). Positive controls are recommended for optimization and ongoing monitoring of delivery conditions and CRISPRi dCas9-SALL1-SDS3 expression prior to experiments with target gene-specific guide RNAs.
Highlights
- Select PPIB1 or SEL1L as your positive control gene
- Choose individual or pooled CRISPRi sgRNA controls to match your experimental CRISPRi sgRNA reagent format
- Ideal for optimization of experimental conditions and confirming successful gene repression
In addition to positive controls, it is recommended to use a CRISPRi synthetic sgRNA non-targeting control to determine baseline levels of gene expression.
Robust gene knockdown with CRISPRi synthetic sgRNA positive controls
Robust transcriptional gene repression with co-delivery of dCas9-SALL1-SDS3 mRNA and CRISPRi synthetic sgRNA positive controls. K562 and Jurkat cells were nucleofected with dCas9-KRAB or dCas9-SALL1-SDS3 mRNA (2 µg), and pooled CRISPRi synthetic sgRNAs (5 µM) targeting PPIB and SEL1L via a Lonza 96-well Shuttle system. WTC-11 hiPS cells were nucleofected with dCas9-KRAB or dCas9-SALL1-SDS3 mRNA (1 µg) and pooled CRISPRi synthetic sgRNA (3 µM) targeting PPPIB or SEL1L via a Lonza 96-well Shuttle system. Cells were harvested 72 hours post-nucleofection. Total RNA was isolated, and relative gene expression was measured using RT-qPCR. The relative gene expression for each target gene was calculated with the Cq method using GAPDH as the housekeeping gene and normalized to a non-targeting control (NTC).
Brochures
Protocols
Safety data sheets
Technical manuals
Related Products
Predesigned CRISPRi synthetic sgRNA for highly efficient gene repression of any human protein-coding gene
Used to evaluate baseline cellular responses to CRISPRi components in the absence of gene target-specific sgRNA
Purified dCas9-SALL1-SDS3 mRNA for co-transfection or electroporation with synthetic CRISPRi sgRNA for repression of targeted gene transcription